Physician profile
John Bottros
NPI 1467635524
$84,680.87
in general payments reported to CMS, 2019-2025
10 companies · $277 in 2025
The $277 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,122 · 2020: $49K · 2021: $9,099 · 2022: $11K · 2023: $1,115 · 2024: $4,502 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,270 · Consulting Fee: $2,209 · Food and Beverage: $1,415.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,270.19 |
| Consulting Fee | $2,208.75 |
| Food and Beverage | $1,414.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Techmah Medical, LLC | $39,280.87 | 2019-2022 | |
| Smith+Nephew, INC. | $36,552.15 | 2019-2024 | Journey II, Real Intelligence, Legion Revision |
| Lima USA, INC. | $2,648.11 | 2019-2020 | |
| Medical Device Business Services, INC. | $2,441.54 | 2023-2025 | Attune, Velys |
| Zimmer Biomet Holdings, INC. | $1,489.87 | 2019-2025 | Persona, Rosa, Gel-One Cross-Linked Hyaluronate |
| Depuy Synthes Sales INC. | $1,377.51 | 2019-2024 | Velys, Actis, Attune |
| Stryker Corporation | $567.55 | 2019-2021 | |
| Limacorporate S.P.A. | $150.00 | 2019 | |
| Si-Bone, INC. | $117.18 | 2019 | |
| Heron Therapeutics, INC. | $56.09 | 2022-2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bottros listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.